Abstract
DRESS (Drug Rash with Eosinophilia and Systemic Symptoms) syndrome is a potentially fatal and probably underrecognized complication of allopurinol. We present the case of a 33 year old male with this condition who required intensive care support and subsequently improved following corticosteroid therapy. We review the literature considering optimal strategies for treatment and prevention of this condition. We believe that acute physicians clinicians should have greater awareness of this complication of allopurinol therapy.
[download-attachments container="div" style="list" display_icon="1" display_count="1" display__size="0"]
References
- Tas S, Simonart T. Management of Drug Rash with Eosinophilia and Systemic Symptoms (DRESS Syndrome): An update. Dermatol 2003; 206: 353–6.
- Zinger J, Wallace S. The allopurinol hypersensitivity syndrome. Unnecessary morbidity and mortality. Arthritis Rheum 1986; 29: 82–7.
- Sullivan JR, Shear NH. The drug hypersensitivity syndrome: What is the pathogenesis? Arch Dermatol 2001; 137: 357–64.
- Descamps V, Valance A, Edlinger C et al. Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms. Arch Dermatol 2001; 137: 301–4.
- Tausche A, Aringer M, Schroeder H et al. The Janus Faces of Allopurinol - Allopurinol Hypersensitivity Syndrome. Am J Med 2008; 121: e3–e4.
- Roujeau JC, Stern RS. Severe adverse reactions to drugs. N Engl J Med 1994; 331: 1272–85.
- Arellano F, Sacristan JA. Allopurinol hypersensitivity syndrome: a review. Ann Pharmacothera 1993; 27: 337–43.
- Chopra S, Levell NJ, Cowley G, Gilkes JJH. Systemic corticosteroids in the phenytoin hypersensitivity syndrome. Br J Dermatol 1996; 134: 1109–12.
- Shalom R, Rimbroth S, Rozemann D, Markel A. Allopurinol-induced recurrent DRESS Syndrome: Pathophysiology and Treatment. Ren Fail 2008; 30: 327–9.
- Trent JT, Kirsner RS, Romanelli P, Kerdel FA. Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami Experience. Arch Dermatol 2003; 139: 39–43.
- Redondo P, de Felipe I, de la Pena A et al. Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis: Treatment with Nacetylcysteine. Br J Dermatol 1997; 136: 645–6.
